Randomised phase II study comparing dose-escalated weekly paclitaxel vs standard-dose weekly paclitaxel for patients with previously treated advanced gastric cancer

Kohei Shitara,Satoshi Yuki,D Tahahari,Michio Nakamura,Chihiro Kondo,Takashi Tsuda,Takayuki Kii,Yasushi Tsuji,Setsuo Utsunomiya,Daisuke Ichikawa,Ayumu Hosokawa,Atsushi Ishiguro,Daisuke Sakai,Shuichi Hironaka,Isao Oze,Keitaro Matsuo,Kei Muro

Randomised phase II study comparing dose-escalated weekly paclitaxel vs standard-dose weekly paclitaxel for patients with previously treated advanced gastric cancer

2014

Kohei Shitara
Satoshi Yuki
D Tahahari
Michio Nakamura
Chihiro Kondo
Takashi Tsuda
Takayuki Kii
Yasushi Tsuji
Setsuo Utsunomiya
Daisuke Ichikawa
Ayumu Hosokawa
Atsushi Ishiguro
Daisuke Sakai
Shuichi Hironaka
Isao Oze
Keitaro Matsuo
Kei Muro

Randomised phase II study comparing dose-escalated weekly paclitaxel vs standard-dose weekly paclitaxel for patients with previously treated advanced gastric cancer

Keywords:

Pathology
Cancer
Phases of clinical research
Medicine
Paclitaxel
General surgery
Surgery
Urology
previously treated
Clinical endpoint
advanced gastric cancer
Neutropenia
weekly paclitaxel
Hazard ratio

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations